PORCINE ILEITIS

Species affected: Porcine

Ileitis, also known as porcine proliferative enteropathy (PE), is caused by L. intracellularis, which infects the intestinal tract. It is one of the most common diseases in swine farms around the world, with huge financial losses.

Mild cases of ileitis mainly develop as a progressive proliferation of immature epithelial cells and don’t trigger a significant inflammatory reaction. If there is inflammation, it is often concentrated in the terminal ileum, near where it connects to the large intestine or colon, although it may also spread to other areas of the small intestine and throughout the large intestine.

Issues can be detected from fattening to the final phases of transition, even affecting first- and second-time mothers. It is rare among sucklings and weanlings under 60 days old.

Risk factors

The risk factors related to this disease are mainly environmental:

Continuous flow farm
Constant infection from one batch to the next seems to be a significant part of the epidemiology.

Environmental changes.

Feed changes.

Many factors contribute to the prevalence and financial impact of L. intracellularis in swine farms, including age, breed, diet, herd health, use of antibiotics, vaccines, disinfectants, handling and production systems.

Main causes

Porcine ileitis is caused by Lawsonia intracellularis, bacteria that can only multiply inside cells. Although it can cause proliferative enteropathy in many mammals, it is seen most often in pigs.

When healthy pigs ingest L. intracellularis, the bacteria begin to multiply in their intestines. The infection peaks within three or four weeks of infection. Generally, infection, lesions and shedding persist for about four weeks. In some cases, however, shedding can last up to 10 weeks. At peak infection, moderate diarrhea and histological lesions can often be observed in three out of four infected animals.

Signs and symptoms

Animals with subclinical ileitis, the most common form of the disease, often present with the following symptoms:

  1. Weight loss
  2. Delay in growth
  3. Mild diarrhea
  4. Sudden death

Clinical ileitis can be broken into three categories based on the symptoms.

Proliferative hemorrhagic enteropathy: the severe acute form of the disease, associated with bloody diarrhea and high death rate. It is most common in young breeding sows.

Porcine intestinal adenomatosis: chronic, uncomplicated form of the disease characterized by thickened mucosa, which may become corrugated. Symptoms include chronic mild to moderate diarrhea.

Necrotic enteritis: chronic complex form of the disease. Animals present with severe diarrhea and wasting.

Financial losses

Proliferative enteropathy causes huge financial losses all over the world. In several European countries, epidemiological studies have put prevalence rates at between 30% and 40% of farms.

As it is often subclinical, especially in transitional swine, the costs of ileitis have been underestimated. The main cause of financial losses associated with ileitis is diminished productivity due to the illness as a result of slower growth, making feed less effective for weight gain.

Another thing that leads to huge losses is increased mortality, whether directly caused by the disease or culling infected animals.

The direct costs of ileitis have been estimated at €5 per sow affected, however this can vary widely depending on the country and severity of the disease or outbreak.

Financial losses

How to fight ileitis

Prevention

There is no one solution for all swine populations, so the best ileitis control and prevention strategy must be chosen to fit the needs of each farm.

However, it is important to remember that L. intracellularis prevalence is high at swine farms around the world and that porcine proliferative enteropathy is endemic. So, it is key to implement a series of measures to help lower cases of ileitis among animals.

  • Strict cleaning and disinfection protocols: key to interrupting the cycle of fecal-oral transmission.
  • Vaccination: essential to reduce the harmful effects of ileitis and lower mortality rates and fecal shedding of L. intracellularis.

Diagnosis

Enteric colibacillosis is diagnosed using productive yield logs, clinical signs, macroscopic lesions and lab results.

  • PCR: This technique can detect very low concentrations of L. intracellularis and is often used to identify animals with clinical or subclinical cases that are currently shedding the bacteria in their feces. Subclinical or chronic cases may give false negatives, so this has to be taken into account.

 

Intestinal samples or fresh feces can be used for PCR testing to detect L. intracellularis DNA. PCR with feces is less sensitive than using the intestinal mucosa, but has the advantage that samples can be taken from live animals.

  • Histology: The lab processes intestinal samples directly to confirm the presence of L. intracellularis. For farms with higher mortality rates and/or clear clinical signs, postmortem testing is an important tool to understand the problem and lay out the best treatment.
  • Serology: Infected animals with high levels of L. intracellularis may have antibodies for up to 12 weeks after infection, while subclinical cases only test positive for 2 to 3 weeks. Serology, as an indirect diagnostic test, can be used to understand how the infection is spreading through the herd and estimate the best time to medicate or vaccinate.

Treatment

Treatment success depends on their ability to eliminate bacteria from the intestinal lumen and cells.

Cases of acute or hemorrhagic proliferative enteropathy require aggressive medication protocols. Sick animals must be medicated with effective antimicrobial injections and the whole batch of animals must be given water with antimicrobials for a specific period and then be reassessed.

When the cases are subclinical, however, they may not present with death but lead to lower growth parameters and greater inequality. Nevertheless, these animals can continue to spread the bacteria and so should be treated with soluble antimicrobials in their drinking water, as sick animals eat less.

Water soluble medications are a good option in large farms because the animals don’t have to be handled and feed remains the same. However, this requires in-line dosing solutions or main water tanks in covered areas or pens to ensure proper dosing.

Treatment with antibiotics like lincomycin has proven effective in controlling symptoms, diarrhea and mortality in acute cases. Combining lincomycin and spectinomycin improves the spectrum of action and helps control possible co-infections caused mainly by E. coli.

Our treatments

BIBLIOGRAPHY

  • Collins, A. M. (2013). Advances in Ileitis Control, Diagnosis, Epidemiology and the Economic Impacts of Disease in Commercial Pig Herds. Agriculture, 3(3), 536-555. DOI: 10.3390/agriculture3030536.
  • Huerta, B., Arenas, A., Carrasco, L., Maldonado, A., Tarradas, C., Carbonero, A., y Perea, A. Comparison of diagnostic techniques for porcine proliferative enteropathy (Lawsonia intracellularis infection). Journal of Comparative Pathology, 2003 Ago-Oct; 129(2-3):179-185. DOI: 10.1016/s0021-9975(03)00030-6.
  • Kroll, J.J., Roof, M.B., Hoffman, L.J., Dickson, J.S., Harris, D.L.H. Proliferative enteropathy: a global enteric disease of pigs caused by Lawsonia intracellularis. Animal Health Research Reviews, 2005; 6(2):173-197. DOI: 10.1079/AHR2005109.
  • McOrist, S. Defining the full costs of endemic porcine proliferative enteropathy. The Veterinary Journal, 2005 Jul; 170(1):8-9. DOI: 10.1016/j.tvjl.2004.04.008.
  • Smith, S. H., McOrist, S., y Green, L. E. Questionnaire survey of proliferative enteropathy on British pig farms. Veterinary Record, 1998; 142:690-693.
  • Szabó, I., Makkai, I., Máté, P., Molnár, T., Swam, H., von Berg, S., Holtkamp, D.J., Glávits, R., Szabó, I., Jr., Ózsvári, L., et al. Slaughterhouse Visual and Palpation Method for Estimating the Economic Damage of Porcine Proliferative Enteropathy (PPE). Animals, 2023; 13:542. DOI: 10.3390/ani13030542.